Samsung Biologics raises 2026 growth outlook as quarterly revenue reaches KRW 1.49 trillion
Samsung Biologics raises 2026 growth outlook as quarterly revenue reaches KRW 1.49 trillion October 22, 2026 | Thursday…
#EuropeSays #Korea #KR #SamsungBiologics #biologics #Biomanufacturing #CDMO #peptidemanufacturing #Plant5 #PolyPeptide #quarterlyresults #rightsoffering #rockville #Samsung
https://www.europesays.com/korea/198599/